01
GHRH
Activates the GHRH receptor and stimulates pituitary growth-hormone release.
GHRH analogue + GHSR agonist, commonly 5 + 5 mg
CJC-1295 No DAC + Ipamorelin
GHRH · GHSR-1a · GH / IGF-1
This blend combines a GHRH signal with a ghrelin-receptor agonist to engage two routes of GH release. The pharmacological rationale is plausible, but the commercial 5+5 mg blend has no randomised clinical trial of its own.
3Overview
1× / dayReference frequency
DataSeparate component studies
Research status
No approved or directly studied fixed combination
CJC-1295 NO DAC + IPAMORELIN10 MG
01 · Overview
What is CJC-1295 No DAC + Ipamorelin?
This blend combines a GHRH signal with a ghrelin-receptor agonist to engage two routes of GH release. The pharmacological rationale is plausible, but the commercial 5+5 mg blend has no randomised clinical trial of its own.
Research route, formulation and population determine what a result actually means.
02
GHSR-1a
Activates the ghrelin/GHS receptor and produces a short GH pulse.
03
GH / IGF-1
An increase in pituitary GH can raise downstream IGF-1 production; this is not direct IGF-1-receptor activation.
02 · Research
What do the studies show?
Separate component studies. Educational information. Not diagnosis, treatment or use advice.
2 routes
No direct studyTheoretical complementarity
Simultaneous receptor activation may amplify GH pulses, but ratio, timing and safety are not clinically validated.
2 h
Human researchIpamorelin PK
In volunteers, ipamorelin had a short terminal half-life and produced a single GH peak; that study did not test the blend.
03 · DATA
Peptide and product specifications
Checked identity data for this research compound or blend.
CJC-1295 No DAC + IpamorelinPeptide and product specifications
Product type
Blend; not a single molecule
Components
CJC-1295 No DAC + Ipamorelin
Nominal composition
CJC-1295 No DAC 5 mg + Ipamorelin 5 mg (totaal 10 mg)
Combined molecular formula
Not applicable to a blend
Combined CAS number
None; see the individual component pages
Purity
Batch-specific — confirm identity and purity with the Velora COA
Reference diluent
Formulation- and batch-specific; there is no universal diluent for every research compound
Unreconstituted-material storage
Follow the accompanying COA, product label and validated stability data
These are compound references, not a batch certificate. Purity and identity of a specific Velora batch must be confirmed by its accompanying COA and laboratory report.
04 · Calculator
Reconstitution and U-100 conversion
This module only converts concentration and volume. Inputs are not recommendations or individual dosing advice.
Calculator
Once daily in educational blend protocols
1
2
3
4
Draw to
0 units
0.00 mL
CJC-1295 NO DAC + IPAMORELIN
10 MG
Concentration—
Per unit—
Complete amounts—
Calculated duration—
LAB · RECONSTITUTION
How to reconstitute CJC-1295 No DAC + Ipamorelin for laboratory research
A visual workflow for controlled laboratory reconstitution. Always follow the product label, COA and a validated protocol.
Clean
Disinfect the rubber closures of both vials and allow them to dry.
Measure diluent
Withdraw only the diluent validated for the specific compound.
Add slowly
Let the liquid run slowly down the inside wall of the vial.
Swirl gently
Do not shake; rotate gently until the material has dissolved.
Store per protocol
Follow the product label, COA and validated stability data.
Important checks before and after reconstitution
Check the product
First confirm that the product is a lyophilised vial. Prefilled pens and ready-to-use solutions do not require reconstitution. Check the label, COA and specified diluent.
Use clean, sterile technique
Wash your hands, clean the work surface and use new sterile equipment for every procedure. Clean both rubber closures with separate alcohol swabs and let them dry completely.
Concentration, not total amount
The volume of liquid added changes the concentration in mg per mL, but not the total amount of research compound in the vial. Use the calculator to check this in advance.
Inspect and label
Check for unexpected discoloration, cloudiness or visible particles. Record the compound, concentration and reconstitution date. Storage time and temperature are product-specific; a fixed 28-day rule does not apply to every compound.
General reconstitution volumes listed by the source
General examples, not a product-specific protocol. The chosen volume determines concentration; always check the label, COA and calculator.
| Vial strength | Commonly listed volume |
|---|---|
| 2 mg | 1–2 mL |
| 5 mg | 2–3 mL |
| 6 mg | 2–3 mL |
| 10 mg | 2–4 mL |
| 15 mg | 3–5 mL |
| 20 mg | 4–8 mL |
Practical background source: Free Medical Journals — Complete Step-by-Step Guide to Peptide Reconstitution, accessed July 2026. This is a secondary educational source; the product label, COA and validated stability data remain authoritative.
05 · Safety and limitations
Safety and limitations
Research route, formulation and population determine what a result actually means.
What is known
- Visible research claims use primary or official sources.
- The calculator is arithmetic and does not turn a study amount into medical advice.
- A registered medicine and a research vial are not automatically equivalent.
What remains uncertain
- Many products lack long-term safety data and independent replication.
- Animal and cell findings do not predict a safe human dose.
- Stability depends on formulation, pH, sterility, light, temperature and packaging.
Status: No approved or directly studied fixed combination. Educational information. Not diagnosis, treatment or use advice.
06 · FAQ
Frequently asked questions
This blend combines a GHRH signal with a ghrelin-receptor agonist to engage two routes of GH release. The pharmacological rationale is plausible, but the commercial 5+5 mg blend has no randomised clinical trial of its own.
Simultaneous receptor activation may amplify GH pulses, but ratio, timing and safety are not clinically validated. In volunteers, ipamorelin had a short terminal half-life and produced a single GH peak; that study did not test the blend.
No. It performs arithmetic conversions only. Medical decisions belong with a licensed healthcare professional.
The curve follows the agreed storage model and is not a laboratory result.
2–8 °C. Protect from light and repeated freeze-thaw cycles.
07 · Sources
Primary research sources
Educational information. Not diagnosis, treatment or use advice.